Back to Search
DOUGLAS PAONE, M.D.
M.D.
Internal Medicine Physician
NPI: 1336245190IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
ME83655(FL)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
UNIVERSITY OF MISSOURI, COLUMBIA SCHOOL OF MEDICINE
Class of 1977
Research & Publications (17)
The syringe gap: an assessment of sterile syringe need and acquisition among syringe exchange program participants in New York City.
PMID 19138414·Harm Reduct J·2009
8-other
Copper-facilitated Suzuki reactions: application to 2-heterocyclic boronates.
PMID 19093828·Org Lett·2009
8-other
Examining the binding properties of MK-0974: a CGRP receptor antagonist for the acute treatment of migraine.
PMID 19084002·Eur J Pharmacol·2009
7-preclinical
Synthesis of the (3R,6S)-3-amino-6-(2,3-difluorophenyl)azepan-2-one of telcagepant (MK-0974), a calcitonin gene-related peptide receptor antagonist for the treatment of migraine headache.
PMID 18590336·Org Lett·2008
8-other
Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine.
PMID 18039958·J Pharmacol Exp Ther·2008
4-observational
Calcitonin gene-related peptide (CGRP) receptor antagonists: investigations of a pyridinone template.
PMID 18039571·Bioorg Med Chem Lett·2008
7-preclinical
Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin- 1-yl)piperidine-1-carboxamide (MK-0974).
PMID 17929795·J Med Chem·2007
7-preclinical
Caprolactams as potent CGRP receptor antagonists for the treatment of migraine.
PMID 17616394·Bioorg Med Chem Lett·2007
7-preclinical
Hepatitis C screening and management practices: a survey of drug treatment and syringe exchange programs in New York City.
PMID 12144980·Am J Public Health·2002
8-other
Concurrent reinforcement schedules: behavior change and maintenance without extinction.
PMID 12102135·J Appl Behav Anal·2002
5-case
The differential effects of face-to-face and computer interview modes.
PMID 11818309·Am J Public Health·2002
3-trial
Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program.
PMID 11684603·Am J Public Health·2001
4-observational
Enantioselective total syntheses of ditryptophenaline and ent-WIN 64821.
PMID 11562239·J Am Chem Soc·2001
8-other
Total synthesis of (-)-cylindrocyclophanes A and F exploiting the reversible nature of the olefin cross metathesis reaction.
PMID 11414825·J Am Chem Soc·2001
8-other
Escape behavior during academic tasks: a preliminary analysis of idiosyncratic establishing operations.
PMID 11214024·J Appl Behav Anal·2000
5-case
Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997.
PMID 10897190·Am J Public Health·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1008 GOODLETTE RD N, STE 202
NAPLES, FL 34102 - Phone
- (239) 263-2808
Quick Facts
- NPI
- 1336245190
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 49
- Publications
- 17
Are you this provider?
Claim Your Profile